These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1823910)

  • 41. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) inhibits HIV-1 replication in epithelial cells, but not T-lymphocytes.
    Srinivas RV; Connely M; Fridland A
    Antiviral Res; 1997 Jun; 35(1):23-7. PubMed ID: 9224958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas.
    Christensen ND; Pickel MD; Budgeon LR; Kreider JW
    Antiviral Res; 2000 Nov; 48(2):131-42. PubMed ID: 11114415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of rat adjuvant arthritis by some acyclic nucleotide analogs.
    Zídek A; Holý A; Franková D; Otová B
    Eur J Pharmacol; 1995 Nov; 286(3):307-10. PubMed ID: 8608793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of phosphonylmethoxyalkyl derivatives studied with a murine model for abortion induced by equine herpesvirus 1.
    Awan AR; Field HJ
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2478-82. PubMed ID: 8285638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
    Smee DF; Bailey KW; Sidwell RW
    Chemotherapy; 2003 Jun; 49(3):126-31. PubMed ID: 12815205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of topical and intralesional cidofovir.
    Zabawski EJ
    Dermatol Online J; 2000 Sep; 6(1):3. PubMed ID: 11328613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
    Johnson JA; Gangemi JD
    Antimicrob Agents Chemother; 1999 May; 43(5):1198-205. PubMed ID: 10223936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures.
    Snoeck R; Holý A; Dewolf-Peeters C; Van Den Oord J; De Clercq E; Andrei G
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3356-61. PubMed ID: 12384336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention.
    Chavez-de la Paz E; Arevalo JF; Kirsch LS; Munguia D; Rahhal FM; De Clercq E; Freeman WR
    Ophthalmology; 1997 Mar; 104(3):539-44. PubMed ID: 9082286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo.
    Balzarini J; Holy A; Jindrich J; Dvorakova H; Hao Z; Snoeck R; Herdewijn P; Johns DG; De Clercq E
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4961-5. PubMed ID: 1711214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase.
    Xiong X; Smith JL; Kim C; Huang ES; Chen MS
    Biochem Pharmacol; 1996 Jun; 51(11):1563-7. PubMed ID: 8630098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells.
    Andrei G; Snoeck R; Schols D; De Clercq E
    Oncol Res; 2000; 12(9-10):397-408. PubMed ID: 11697818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine on the replication and morphogenesis of herpes simplex virus type 1.
    Chatterjee S; Burns P; Whitley RJ; Kern ER
    Antiviral Res; 1992 Sep; 19(3):181-92. PubMed ID: 1332603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cidofovir in the treatment of poxvirus infections.
    De Clercq E
    Antiviral Res; 2002 Jul; 55(1):1-13. PubMed ID: 12076747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
    Snoeck R; Andrei G; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):574-9. PubMed ID: 8874075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative activity of various compounds against clinical strains of herpes simplex virus.
    Andrei G; Snoeck R; Goubau P; Desmyter J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):143-51. PubMed ID: 1327785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule.
    Miller DS
    J Pharmacol Exp Ther; 2001 Nov; 299(2):567-74. PubMed ID: 11602668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-Phosphoribosyl 1-pyrophosphate synthetase converts the acyclic nucleoside phosphonates 9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 9-(2-phosphonylmethoxyethyl)adenine directly to their antivirally active diphosphate derivatives.
    Balzarini J; De Clercq E
    J Biol Chem; 1991 May; 266(14):8686-9. PubMed ID: 1851154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonates.
    Caliò R; Villani N; Balestra E; Sesa F; Holy A; Balzarini J; De Clercq E; Perno CF; Del Gobbo V
    Antiviral Res; 1994 Jan; 23(1):77-89. PubMed ID: 7511362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.